Changes in characteristics and outcomes of critically ill COVID-19 patients in Tyrol (Austria) over 1 yearTimo Mayerhöfer, Michael Joannidis, Eva Foidl et al.|Wiener klinische Wochenschrift|2021Cited by 23
Incidence, risk factors and outcome of acute kidney injury in critically ill COVID-19 patients in Tyrol, Austria: a prospective multicenter registry studyTimo Mayerhöfer, Michael Joannidis, Fabian Perschinka et al.|Journal of Nephrology|2023Cited by 14
Elevated HbA1c remains a predominant finding in severe COVID-19 and may be associated with increased mortality in patients requiring mechanical ventilationSebastian Klein, Claudius Thomé, Timo Mayerhöfer et al.|Critical Care|2021Cited by 12
High bicarbonate replacement fluid and time to pH normalization during continuous veno-venous hemofiltration with regional citrate anticoagulation: a retrospective single-center cohort studyTimo Mayerhöfer, Michael Joannidis, Paul Köglberger et al.|Clinical Kidney Journal|2025Cited by 3
Soluble Neuropilin-1 as a Marker for Distinguishing Bacterial and Viral Sepsis in Critically Ill Patients—A Prospective, Multicenter, Observational StudyFabian Perschinka, Michael Joannidis, Georg Lehner et al.|Viruses|2025Cited by 1